Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10680	Companies
228001	Keywords
156512	Articles
120874	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 02/07/2025 at 01:30, 1 year 4 months ago

Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations announces Expression of Interest with Quantify Research, a global healthcare data analytics leader, to explore collaborations in advanced data analytics and oncology research

Oncology Research Healthcare Data Analytics Onco-Innovations Quantify Research EOI
BRIEF

published on 02/04/2025 at 05:41, 1 year 5 months ago

Onco-Innovations Acquires Inka Health to Boost Cancer Research with AI

Acquisition Innovation AI Technology Oncology Cancer Research
BRIEF

published on 02/04/2025 at 05:41, 1 year 5 months ago

Onco-Innovations acquiert Inka Health pour stimuler la recherche sur le cancer grâce à l'IA

Acquisition Innovation Oncologie Technologie De L'IA Recherche Sur Le Cancer
PRESS RELEASE

published on 02/04/2025 at 05:36, 1 year 5 months ago

Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development
Onco-Innovations Limited completes acquisition of Inka Health Corp, a Canadian-based software company pioneering AI-driven analytics in cancer research and drug development. Strengthens precision oncology capabilities

Acquisition AI Technology Precision Oncology Onco-Innovations Inka Health
BRIEF

published on 01/30/2025 at 23:05, 1 year 5 months ago

Onco-Innovations' PNKP Inhibitors Display Potential in Cancer Therapy

Cancer Therapy Drug Resistance PNKP Inhibitors DNA Repair Chemo Enhancement
BRIEF

published on 01/30/2025 at 23:05, 1 year 5 months ago

Les inhibiteurs PNKP d'Onco-Innovations présentent un potentiel dans le traitement du cancer

Thérapie Contre Le Cancer Inhibiteurs De La PNKP Réparation De L'ADN Résistance Aux Médicaments Amélioration De La Chimio
PRESS RELEASE

published on 01/30/2025 at 23:00, 1 year 5 months ago

Onco-Innovations' Licensed Technology Shows Promise in Enhancing Chemotherapy Effectiveness by Overcoming Cancer Cell Resistance and Inhibiting Cancer Cell Repair
Onco-Innovations announces breakthrough Technology enhancing cancer treatment efficacy by inhibiting DNA repair in cancer cells, potentially improving patient outcomes in a multi-billion-dollar market

Patient Outcomes Cancer Treatment Onco-Innovations DNA Repair Inhibitors Cancer Therapy Market
BRIEF

published on 01/29/2025 at 22:50, 1 year 5 months ago

Onco-Innovations' Private Placement Fully Subscribed

Private Placement Securities Market Confidence Onco-Innovations Fully Subscribed
BRIEF

published on 01/29/2025 at 22:50, 1 year 5 months ago

Le placement privé d'Onco-Innovations est entièrement souscrit

Placement Privé Titres Confiance Du Marché Innovations Oncologiques Entièrement Abonné
PRESS RELEASE

published on 01/29/2025 at 22:45, 1 year 5 months ago

Onco-Innovations' Private Placement Fully Subscribed
Onco-Innovations Limited announces the full subscription of its non-brokered private placement, closing soon. Investors show strong confidence in the company's vision and mission in cancer research and treatment

Private Placement Investors Closing Date Cancer Research Onco-Innovations Limited

Accesswire

Published on 07/03/2026 at 23:00, 13 hours 59 minutes ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 13 hours 59 minutes ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 15 hours 31 minutes ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 17 hours 29 minutes ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 23 hours 29 minutes ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/04/2026 at 11:01, 1 hour 57 minutes ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 3 hours 53 minutes ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 17 hours 59 minutes ago

PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 18 hours 3 minutes ago

Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 18 hours 44 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 07/03/2026 at 21:49, 15 hours 9 minutes ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 15 hours 9 minutes ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 18 hours 16 minutes ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 18 hours 16 minutes ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 18 hours 22 minutes ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE